 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.004.311 |
| Chemical and physical data | |
| Formula | C22H28BrNO3 |
| Molar mass | 434.374 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Pipenzolate bromide is a pharmaceutical drug that has been studied as anantispasmodic agent and to treatpeptic ulcer.[1]
Pipenzolate bromide acts as anantimuscarinic agent. It binds tomuscarinic acetylcholine receptors as anantagonist therefore preventingacetylcholine from binding to the receptors.[1]
 | Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |